Identification of therapeutic targets for bladder cancer patients overexpressing OPN

JW Janet P.C. Wong
RW Ran Wei
PL Peng Lyu
OT Olivia L.H. Tong
SZ Shu Dong Zhang
QW Qing Wen
HY Hiu Fung Yuen
ME Mohamed El-Tanani
HK Hang Fai Kwok
request Request a Protocol
ask Ask a question
Favorite

Patients who had their tumors expressing a high-level of OPN were stratified into two groups based on their survival status (alive or deceased). Differential expressions of different probesets between patients in the OPN high-alive subgroup and those in the OPN high-deceased subgroup were identified as described above.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A